Homepage
Medication Guide
Purchase Channels for Xphozah (Tenapanor)
Xphozah (Tenapanor) is a sodium-hydrogen exchanger 3 (NHE3) inhibitor with tenapanor hydrochloride as the active ingredient. First approved in the United States in 2019, this medication is primarily u...
501
Monday, November 17th, 2025, 09:58
Side Effects of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch system containing 8% capsaicin, indicated for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and diabetic peripheral neurop...
501
Monday, November 17th, 2025, 09:49
What Are the Precautions for Using Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a transdermal drug delivery system containing 8% capsaicin (640 micrograms per square centimeter), which was first approved in the United States in 2009. As a TRPV1 channe...
502
Monday, November 17th, 2025, 09:37
Dosage and Administration of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is an FDA-approved topical medication for the treatment of postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN). Its unique ...
502
Monday, November 17th, 2025, 09:33
What Are the Indications for Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a therapeutic medication approved by the U.S. Food and Drug Administration (FDA), providing an innovative treatment option for patients with specific types of neuropathic ...
503
Monday, November 17th, 2025, 09:28
Purchase Channels for Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch containing 8% capsaicin, classified as a TRPV1 channel agonist. In July 2020, this medication was approved by the U.S. FDA for the treatment of foot neural...
503
Monday, November 17th, 2025, 09:24
What Are the Side Effects of Epalrestat?
Epalrestat is a selective aldose reductase inhibitor. Since its approval in Japan in 1992, it has been mainly used for the treatment of diabetic peripheral neuropathy. Similar to other medications, Ep...
503
Monday, November 17th, 2025, 09:22
What are the Precautions for Taking Epalrestat?
Epalrestat is an aldose reductase inhibitor. Since its approval in Japan in 1992, it has been widely used as an adjuvant treatment for diabetic peripheral neuropathy.What are the Precautions for Takin...
504
Monday, November 17th, 2025, 09:18
Dosage and Administration of Epalrestat: Recommended Dosage
Epalrestat is a selective aldose reductase inhibitor. Since its approval in Japan in 1992, it has become an important therapeutic agent for diabetic peripheral neuropathy.Dosage and Administration of ...
504
Friday, November 14th, 2025, 14:02
What Are the Indications of Epalrestat?
Epalrestat is an aldose reductase inhibitor that holds an important position in the treatment of diabetic complications. Since its first approval in Japan in 1992, it has become one of the key medicat...
503
Friday, November 14th, 2025, 13:28
33 / 185
1842 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved